StopDown
Funding · 7 January 2026Be ClinicalRs 6 croreEvidence-led skincare for ageingbe-clinical.com ↗

Be Clinical raises Rs 6 crore in extended seed

By · Editor ·

extended seedFounded 2024
  • Be Clinical is an evidence-led skincare brand offering clinically tested solutions for ageing skin, focusing on face, body, and scalp
  • The company raised Rs 6 crore in an extended seed round led by V3 Ventures, with participation from Titan Capital
  • Funds will boost R&D, in-house formulation, and manufacturing expansion, targeting India's gap in science-led anti-ageing products

What happened

  • Be Clinical raised Rs 6 crore in an extended seed round led by V3 Ventures.
  • Titan Capital, founded by Kunal Bahl and Rohit Bansal, participated in this tranche.
  • The round's earlier tranche of Rs 2 crore was led by Titan Capital, with Aditya Agarwal of P-TAL also investing.
  • Founder Hemangi Dhir launched the brand in May 2024.
  • The company will use the funds for R&D, in-house formulation, and clinical testing.
  • Plans include expanding the manufacturing facility with advanced machinery.
  • The company will also upgrade packaging to functional, protective, and premium formats.
  • Be Clinical has served over 25,000 customers since inception.

Why it matters

  • The brand addresses a market gap: a lack of science-led, transparent, clinically validated skincare solutions for Indian skin.
  • Its differentiation lies in in-vivo tested and clinically validated formulations, with end-to-end in-house research and manufacturing.
  • The funding signals growing investor interest in evidence-based beauty brands in India.
  • Competitors include Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing segment.

The business

  • Be Clinical is an evidence-led skincare brand focused on ageing concerns across face, body, and scalp.
  • Products include Neck Repair Skin Tightening Night Cream, PlumpX Serum, FirmX Serum, Blemish Balance Serum, and SmoothX Hand Cream.
  • Prices range from Rs 999 to Rs 2,998.
  • The company offers free shipping on orders over Rs 100.
  • Clinical trials are registered on the Clinical Trial Registry of India.
  • Customer reviews mention visible improvement and suitability for sensitive skin.
  • The brand operates with an end-to-end in-house research and manufacturing model.

The founders

Hemangi Dhir

Founder
in
  • Launched Be Clinical in May 2024.
  • Leads the brand's vision for clinically validated skincare solutions for Indian skin.

Who put in money

In numbers

Rs 6 croreAmount raised · 2026
Rs 2 crorePrevious tranche · 2026
25,000+Customers served · 2026
Rs 999 - Rs 2,998Product price range · 2026
Rs 100Free shipping threshold · 2026

What happens next

  • Expand manufacturing facility with advanced machinery.
  • Upgrade packaging to functional, protective, and premium formats.
  • Continue R&D and clinical testing for targeted ageing solutions.

Earlier rounds

  • 2026-01-07 · extended seed · Rs 6 crore · led by V3 Ventures
  • 2026-01-07 · seed (previous tranche) · Rs 2 crore · led by Titan Capital

Up against

OlayNeutrogenaCliniqueDr. Sheth

Words to know

extended seed
An additional funding round for a startup, typically after an initial seed round, to support early growth.
in-vivo
Tested on living organisms, such as human skin, rather than in a lab dish.
R&D
Research and development, the work a company does to create new products or improve existing ones.
clinical trial
A scientific study to test how well a product works in people, often registered for transparency.

The numbers around it

Be Clinical has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
22 August 2026seed₹21 CrSauce

Commerce & Consumer Brands in January 2026: 32 rounds with a disclosed amount, $292 million in all; the biggest was iD Fresh (₹1,300 Cr). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

Everything on Be Clinical → · All startup news on 7 January 2026 →

Is this Be Clinical? Get your “Featured on StopDown” badge →